Literature DB >> 8291724

Revised label regarding use of succinylcholine in children and adolescents.

R C Morell, J M Berman, R I Royster, P H Petrozza, J S Kelly, D M Colonna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8291724     DOI： 10.1097/00000542-199401000-00046

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

1.  FDA group urges sux label reduced to "warning".

Authors:  R C Morell
Journal:  J Clin Monit       Date:  1995-03

2.  In my opinion: a debate--can succinylcholine be used routinely with safety in children?

Authors:  S K Woelfel; R C Morell; J M Berman
Journal:  J Clin Monit       Date:  1994-11

3.  Atropine and succinylcholine: beliefs and controversies in paediatric anaesthesia.

Authors:  V F Blanc
Journal:  Can J Anaesth       Date:  1995-01       Impact factor: 5.063

Review 4.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 5.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.